John Poyhonen Heron Therapeutics, Inc. (HRTX) insider trading activity

John Poyhonen is President & CCO of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 46,648 shares of HRTX, which is worth approximately $72,304. The most recent transaction as insider was on Apr 13, 2023, when has been sold 2,012 shares (Common Stock) at a price of $2.88 per share, resulting in proceeds of $5,794. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.6K

0% 3M change

0% 12M change

Total Value Held $72,304

JOHN POYHONEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 13 2023	SELL Payment of exercise price or tax liability	$5,794 $2.88 p/Share	2,012 Reduced 4.13%	46,648 Common Stock
Apr 13 2023	BUY Exercise of conversion of derivative security	-	5,814 Added 10.67%	48,660 Common Stock
Jan 13 2023	SELL Payment of exercise price or tax liability	$6,378 $3.17 p/Share	2,012 Reduced 4.49%	42,846 Common Stock
Jan 13 2023	BUY Exercise of conversion of derivative security	-	5,814 Added 11.47%	44,858 Common Stock
Oct 13 2022	SELL Payment of exercise price or tax liability	$7,565 $3.76 p/Share	2,012 Reduced 4.9%	39,044 Common Stock
Oct 13 2022	BUY Exercise of conversion of derivative security	-	5,814 Added 12.4%	41,056 Common Stock
Jul 13 2022	SELL Payment of exercise price or tax liability	$6,056 $3.01 p/Share	2,012 Reduced 5.4%	35,242 Common Stock
Jul 13 2022	BUY Exercise of conversion of derivative security	-	5,814 Added 13.5%	37,254 Common Stock
Apr 13 2022	SELL Payment of exercise price or tax liability	$12,213 $6.07 p/Share	2,012 Reduced 6.01%	31,440 Common Stock
Apr 13 2022	BUY Exercise of conversion of derivative security	-	5,814 Added 14.81%	33,452 Common Stock
Jan 13 2022	SELL Payment of exercise price or tax liability	$16,700 $8.3 p/Share	2,012 Reduced 6.79%	27,638 Common Stock
Jan 13 2022	BUY Exercise of conversion of derivative security	-	5,814 Added 16.39%	29,650 Common Stock
Oct 29 2021	BUY Other acquisition or disposition	$7,647 $9.36 p/Share	817 Added 3.31%	23,836 Common Stock
Oct 13 2021	SELL Payment of exercise price or tax liability	$4,568 $10.55 p/Share	433 Reduced 1.85%	23,019 Common Stock
Oct 13 2021	BUY Exercise of conversion of derivative security	-	1,250 Added 5.06%	23,452 Common Stock
Jul 13 2021	SELL Payment of exercise price or tax liability	$5,837 $13.48 p/Share	433 Reduced 1.91%	22,202 Common Stock
Jul 13 2021	BUY Exercise of conversion of derivative security	-	1,250 Added 5.23%	22,635 Common Stock
Apr 30 2021	BUY Other acquisition or disposition	$13,497 $13.9 p/Share	971 Added 4.34%	21,385 Common Stock
Apr 13 2021	SELL Payment of exercise price or tax liability	$7,214 $16.66 p/Share	433 Reduced 2.08%	20,414 Common Stock
Apr 13 2021	BUY Exercise of conversion of derivative security	-	1,250 Added 5.66%	20,847 Common Stock
Jan 13 2021	SELL Payment of exercise price or tax liability	$7,863 $18.16 p/Share	433 Reduced 2.16%	19,597 Common Stock
Jan 13 2021	BUY Exercise of conversion of derivative security	-	1,250 Added 5.87%	20,030 Common Stock
Oct 30 2020	BUY Other acquisition or disposition	$7,421 $11.65 p/Share	637 Added 3.28%	18,780 Common Stock

John Poyhonen

President & CCO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Heron Therapeutics, Inc. insider buys or sells HRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to HERON THERAPEUTICS, INC.

Track Activities on HRTX

Account